310 related articles for article (PubMed ID: 31788078)
21. Identification of differentially expressed genes, associated functional terms pathways, and candidate diagnostic biomarkers in inflammatory bowel diseases by bioinformatics analysis.
Cheng C; Hua J; Tan J; Qian W; Zhang L; Hou X
Exp Ther Med; 2019 Jul; 18(1):278-288. PubMed ID: 31258663
[TBL] [Abstract][Full Text] [Related]
22. High gene expression levels of VEGFA and CXCL8 in the peritumoral brain zone are associated with the recurrence of glioblastoma: A bioinformatics analysis.
Luo X; Xu S; Zhong Y; Tu T; Xu Y; Li X; Wang B; Yang F
Oncol Lett; 2019 Dec; 18(6):6171-6179. PubMed ID: 31788092
[TBL] [Abstract][Full Text] [Related]
23. Aberrantly methylated-differentially expressed genes and pathways in colorectal cancer.
Liu J; Li H; Sun L; Wang Z; Xing C; Yuan Y
Cancer Cell Int; 2017; 17():75. PubMed ID: 28794688
[TBL] [Abstract][Full Text] [Related]
24. Bioinformatics-Based Identification of Methylated-Differentially Expressed Genes and Related Pathways in Gastric Cancer.
Li H; Liu JW; Liu S; Yuan Y; Sun LP
Dig Dis Sci; 2017 Nov; 62(11):3029-3039. PubMed ID: 28914394
[TBL] [Abstract][Full Text] [Related]
25. Identification of key microRNAs and their targets in exosomes of pancreatic cancer using bioinformatics analysis.
Zhao X; Ren Y; Cui N; Wang X; Cui Y
Medicine (Baltimore); 2018 Sep; 97(39):e12632. PubMed ID: 30278585
[TBL] [Abstract][Full Text] [Related]
26. Identification of key DNA methylation-driven genes in prostate adenocarcinoma: an integrative analysis of TCGA methylation data.
Xu N; Wu YP; Ke ZB; Liang YC; Cai H; Su WT; Tao X; Chen SH; Zheng QS; Wei Y; Xue XY
J Transl Med; 2019 Sep; 17(1):311. PubMed ID: 31533842
[TBL] [Abstract][Full Text] [Related]
27. Identification of key pathways and biomarkers in sorafenib-resistant hepatocellular carcinoma using bioinformatics analysis.
Huang D; Yuan W; Li H; Li S; Chen Z; Yang H
Exp Ther Med; 2018 Sep; 16(3):1850-1858. PubMed ID: 30186410
[TBL] [Abstract][Full Text] [Related]
28. Identification of hub genes associated with outcome of clear cell renal cell carcinoma.
Li R; Wang L; Wang X; Geng RX; Li N; Liu XH
Oncol Lett; 2020 Apr; 19(4):2846-2860. PubMed ID: 32218839
[TBL] [Abstract][Full Text] [Related]
29. Identification of aberrantly methylated differentially expressed genes in breast cancer by integrated bioinformatics analysis.
Yi L; Luo P; Zhang J
J Cell Biochem; 2019 Sep; 120(9):16229-16243. PubMed ID: 31081184
[TBL] [Abstract][Full Text] [Related]
30. Identification of core genes and prediction of miRNAs associated with osteoporosis using a bioinformatics approach.
Chai Y; Tan F; Ye S; Liu F; Fan Q
Oncol Lett; 2019 Jan; 17(1):468-481. PubMed ID: 30655789
[TBL] [Abstract][Full Text] [Related]
31. Bioinformatics analysis of fibroblasts exposed to TGF‑β at the early proliferation phase of wound repair.
Mi B; Liu G; Zhou W; Lv H; Zha K; Liu Y; Wu Q; Liu J
Mol Med Rep; 2017 Dec; 16(6):8146-8154. PubMed ID: 28983581
[TBL] [Abstract][Full Text] [Related]
32. Identification of hub-methylated differentially expressed genes in patients with gestational diabetes mellitus by multi-omic WGCNA basing epigenome-wide and transcriptome-wide profiling.
Chen M; Yan J; Han Q; Luo J; Zhang Q
J Cell Biochem; 2020 Jun; 121(5-6):3173-3184. PubMed ID: 31886571
[TBL] [Abstract][Full Text] [Related]
33. Identifying the key genes and microRNAs in colorectal cancer liver metastasis by bioinformatics analysis and in vitro experiments.
Zhang T; Guo J; Gu J; Wang Z; Wang G; Li H; Wang J
Oncol Rep; 2019 Jan; 41(1):279-291. PubMed ID: 30542696
[TBL] [Abstract][Full Text] [Related]
34. Identification of core genes and outcome in gastric cancer using bioinformatics analysis.
Sun C; Yuan Q; Wu D; Meng X; Wang B
Oncotarget; 2017 Sep; 8(41):70271-70280. PubMed ID: 29050278
[TBL] [Abstract][Full Text] [Related]
35. Identification of Key Biomarkers and Potential Molecular Mechanisms in Renal Cell Carcinoma by Bioinformatics Analysis.
Li F; Guo P; Dong K; Guo P; Wang H; Lv X
J Comput Biol; 2019 Nov; 26(11):1278-1295. PubMed ID: 31233342
[No Abstract] [Full Text] [Related]
36. Identification of aberrantly methylated differentially expressed genes in prostate carcinoma using integrated bioinformatics.
Wu K; Yin X; Jin Y; Liu F; Gao J
Cancer Cell Int; 2019; 19():51. PubMed ID: 30872976
[TBL] [Abstract][Full Text] [Related]
37. Significant prognostic values of differentially expressed-aberrantly methylated hub genes in breast cancer.
Qi L; Zhou B; Chen J; Hu W; Bai R; Ye C; Weng X; Zheng S
J Cancer; 2019; 10(26):6618-6634. PubMed ID: 31777591
[No Abstract] [Full Text] [Related]
38. Osteoarthritis related epigenetic variations in miRNA expression and DNA methylation.
Jin L; Ma J; Chen Z; Wang F; Li Z; Shang Z; Dong J
BMC Med Genomics; 2023 Jul; 16(1):163. PubMed ID: 37434153
[TBL] [Abstract][Full Text] [Related]
39. Integrative genomics analysis of hub genes and their relationship with prognosis and signaling pathways in esophageal squamous cell carcinoma.
Chen FF; Zhang SR; Peng H; Chen YZ; Cui XB
Mol Med Rep; 2019 Oct; 20(4):3649-3660. PubMed ID: 31485619
[TBL] [Abstract][Full Text] [Related]
40. Examining the biomarkers and molecular mechanisms of medulloblastoma based on bioinformatics analysis.
Yang B; Dai JX; Pan YB; Ma YB; Chu SH
Oncol Lett; 2019 Jul; 18(1):433-441. PubMed ID: 31289514
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]